Concepedia

Vaishali Sahasrabudhe

VS

Statistics

Publications

17

Citations

487

H-Index

16

Active since

2006

Affiliations

Pfizer (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Pfizer (France)

Otsuka (United States)

United States Food and Drug Administration

Vaishali Sahasrabudhe is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2006–2025

17

Publications

17

The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism

Rena J Eudy, Vaishali Sahasrabudhe, Kevin Sweeney et al. · Journal of Translational Medicine · 2011 · 55 citations · Full text

An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder

Robert L. Findling, Ralph E. Kauffman, Floyd R. Sallee et al. · Journal of Child and Adolescent Psychopharmacology · 2009 · 53 citations

The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus

Vaishali Sahasrabudhe, Steven G. Terra, A. Hickman et al. · The Journal of Clinical Pharmacology · 2017 · 47 citations · Full text

A proposal for scientific framework enabling specific population drug dosing recommendations

Pravin Jadhav, Jack Cook, Vikram Sinha et al. · The Journal of Clinical Pharmacology · 2015 · 44 citations · Full text

, , +18

Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin

Sangeeta Raje, Ernesto Callegari, Vaishali Sahasrabudhe et al. · Clinical and Translational Science · 2018 · 38 citations · Full text

1–5 of 17